Viral ‘molecular scissor’ is next COVID-19 drug target

Inhibiting the SARS-CoV-2-PLpro enzyme is a novel avenue to explore in rational design of COVID-19 drugs, according to new research from The University of Texas Health Science Center at San Antonio and collaborators in Wroclaw, Poland.